Cosan S.A.
NYSE:CSANOil & Gas Refining & Marketing
-$0.02 today
- Market cap
- $2.69B
- Beta
- 0.45
- P/E (TTM)
- -1.4
- EPS (TTM)
- -$2.43
Volume 2.36M
Average 2.37M
CSAN Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Cosan S.A.NYSE: CSAN
Research & Development · Q2 FY2026 · quarter ended Jun 2026
Research & development remains negative
Q2 FY2026 research & development was R$0, compared with R$0 a year earlier. Trailing-twelve-month research & development was R$0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near R$0 or moves back toward the trailing-twelve-month quarterly average of R$0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
BRL · from the income statement
- Latest · FY2025
- 0 BRL
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How CSAN compares with its peers on the latest reported figures
- Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
- Research & development amounts to 0.0% of revenue for CSAN, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $209.41M USD | -20.6% | -8.6% | 16.4% | |
| LTM Jun 2026 | R$0 BRL | — | — | 0.0% | |
| LTM Jun 2026 | $0 USD | — | — | 0.0% | |
| LTM Sep 2026 | $0 USD | — | — | 0.0% | |
| LTM Sep 2026 | $0 USD | — | — | 0.0% | |
| LTM Jun 2026 | $0 USD | -100.0% | — | 0.0% | |
| LTM Jun 2026 | $0 USD | — | — | 0.0% | |
| LTM Jun 2026 | $0 USD | — | — | 0.0% | |
| LTM Sep 2026 | $0 USD | — | — | 0.0% | |
| LTM Sep 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding CSAN) | — | -60.3% | -8.6% | 0.0% | |
Competitors are the stored peer set for CSAN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 26.09B | 39.32B | 39.47B | 43.95B | 40.42B |
| Cost of Revenue | 20.26B | 30.56B | 28.55B | 30.24B | 27.24B |
| Gross Profit | 5.83B | 8.77B | 10.92B | 13.71B | 13.18B |
| Gross Margin | 22.3% | 22.3% | 27.7% | 31.2% | 32.6% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 2.12B | 3.03B | 3.88B | 4.42B | 4.38B |
| Operating Expenses | 1.93B | 2.81B | 3.33B | 4.42B | 2.46B |
| Depreciation & Amortization | 2.5B | 3.01B | 3.36B | 3.26B | 3.89B |
| EBITDA | 12.65B | 11.14B | 14.12B | 13.22B | 3.64B |
| EBITDA Margin | 48.5% | 28.3% | 35.8% | 30.1% | 9.0% |
| Operating Income | 3.9B | 5.96B | 7.59B | 9.29B | 10.71B |
| Operating Margin | 15.0% | 15.1% | 19.2% | 21.1% | 26.5% |
| Interest Income | 1.01B | 2.18B | 2.51B | 2.44B | 3.23B |
| Interest Expense | 3.89B | 5.47B | 5.64B | 7.15B | 7.74B |
| Other Income / Expenses | 2.35B | (3.3B) | (2.47B) | (14.54B) | (18.7B) |
| Income Before Tax | 6.25B | 2.65B | 5.11B | (5.25B) | (7.99B) |
| Pre-Tax Margin | 24.0% | 6.7% | 13.0% | -11.9% | -19.8% |
| Income Tax Expense | (445.58M) | (118.4M) | 274.43M | 3.19B | 2.2B |
| Net Income | 6.31B | 1.18B | 1.09B | (9.42B) | (9.72B) |
| Net Margin | 24.2% | 3.0% | 2.8% | -21.4% | -24.1% |
| EPS (Basic) | 3.34 | 1.52 | 0.60 | (5.36) | (7.64) |
| EPS (Diluted) | 3.34 | 1.50 | 0.58 | (5.20) | (7.64) |
| Weighted Avg Shares | 1.83B | 1.87B | 1.87B | 1.81B | 1.25B |
| Weighted Avg Shares (Diluted) | 1.84B | 1.87B | 1.87B | 1.86B | 1.25B |
Cosan S.A.
NYSE:CSAN
Intrinsic Alpha fair value
Locked
Current Price
$2.75
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.